Business
from24/7 Wall St.
1 week agoPfizer's Q3 Earnings Beat on Top and Bottom Lines
Pfizer delivered stronger-than-expected adjusted EPS, raised EPS guidance, and showed non-COVID product growth while overall revenue and net income declined year over year.